SLQT logo

SelectQuote, Inc. Stock Price

NYSE:SLQT Community·US$148.6m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

SLQT Share Price Performance

US$0.85
-1.35 (-61.25%)
US$3.06
Fair Value
US$0.85
-1.35 (-61.25%)
72.2% undervalued intrinsic discount
US$3.06
Fair Value
Price US$0.85
AnalystConsensusTarget US$3.06
AnalystHighTarget US$5.00
AnalystLowTarget US$1.25

SLQT Community Narratives

·
Fair Value US$3.06 72.2% undervalued intrinsic discount

Healthcare Services And Medicare Will Boost Future Momentum Amid Risks

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$5 83.0% undervalued intrinsic discount

Aging And Digital Trends Will Fuel Medicare Demand Amid Hurdles

1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$1.25 31.8% undervalued intrinsic discount

Digital And Regulatory Challenges Will Squeeze Margins Yet Kindle Progress

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$5
83.0% undervalued intrinsic discount
Revenue
6.73% p.a.
Profit Margin
11.06%
Future PE
5.51x
Price in 2029
US$6.49

Trending Discussion

Updated Narratives

SLQT logo

SLQT: Earnings Outlook And Margin Improvement Will Support Future Upside Potential

Fair Value: US$5 83.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SLQT logo

SLQT: Local Franchise Rollout And FY26 Guidance Will Support Future P/E Re Rating

Fair Value: US$1.25 31.8% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SLQT logo

SLQT: Reset Expectations And Pharmacy Agreement Will Support Future Upside

Fair Value: US$3.06 72.2% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Acceptable track record with low risk.

3 Risks
2 Rewards

SelectQuote, Inc. Key Details

US$1.6b

Revenue

US$1.1b

Cost of Revenue

US$576.1m

Gross Profit

US$555.4m

Other Expenses

US$20.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.12
35.09%
1.26%
56.6%
View Full Analysis

About SLQT

Founded
1999
Employees
4269
CEO
Timothy Danker
WebsiteView website
www.selectquote.com

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; HomeTM (PCPH), an accredited pharmacy; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners’ insurance. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.

Recent SLQT News & Updates

Narrative Update Jun 06

SLQT: Earnings Outlook And Margin Improvement Will Support Future Upside Potential

Analysts have revised their SelectQuote price target to $5.00 to reflect updated assumptions, including a slightly lower revenue growth outlook, a modestly higher profit margin, and a revised discount rate and forward P/E that together indicate a more measured risk and valuation profile. What's in the News SelectQuote reaffirmed earnings guidance for Fiscal Year 2026, with revenue expected in a range of US$1.61b to US$1.71b.
Narrative Update May 21

SLQT: Local Franchise Rollout And FY26 Guidance Will Support Future P/E Re Rating

Analysts have adjusted their price target on SelectQuote to $1.25, with the change mainly tied to updated assumptions for the discount rate, revenue growth, profit margin, and future P/E rather than a shift in their overall fair value estimate. What's in the News SelectQuote reaffirmed its earnings guidance for Fiscal Year 2026, calling for revenue in a range of US$1.61b to US$1.71b (Key Developments).

Recent updates

No updates